Chronic kidney disease in US adults with type 2 diabetes: An updated national estimate of prevalence based on Kidney Disease: Improving Global Outcomes (KDIGO) staging

BMC Research Notes

Volumn 7, Issue 1, 2014, Pages

  Bailey, Robert A ^a   Wang, Yiting ^a   Zhu, Vivienne ^a   Rupnow, Marcia Ft ^a  

^a JANSSEN RESEARCH AND DEVELOPMENT   (United States)

Author keywords

Albuminuria; Chronic kidney disease; Diabetes; Estimated glomerular filtration rate; Prevalence; Type 2 diabetes mellitus

Indexed keywords

ADULT; AGED; ALBUMINURIA; COMPLICATION; DIABETES MELLITUS, TYPE 2; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; MALE; MIDDLE AGED; NUTRITION; PATHOPHYSIOLOGY; PREVALENCE; RENAL INSUFFICIENCY, CHRONIC; SEVERITY OF ILLNESS INDEX; UNITED STATES;

ADULT; AGED; ALBUMINURIA; DIABETES MELLITUS, TYPE 2; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; MALE; MIDDLE AGED; NUTRITION SURVEYS; PREVALENCE; RENAL INSUFFICIENCY, CHRONIC; SEVERITY OF ILLNESS INDEX; UNITED STATES;

EID: 84903406894     PISSN: None     EISSN: 17560500     Source Type: Journal    
DOI: 10.1186/1756-0500-7-415     Document Type: Article

References (26)

1. Antidiabetic medication use and prevalence of chronic kidney disease among patients with type 2 diabetes mellitus in the United States. Koro CE, Lee BH, Bowlin SJ, Clin Ther 2009 31 2608 2617
2. USRDS 2013 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States. U.S. Renal Data System, Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2013. [ http://www.usrds.org/atlas.aspx ]
3. Direct all-cause health care costs associated with chronic kidney disease in patients with diabetes and hypertension: a managed care perspective. Laliberte R, Bookhart B, Vekeman F, Corral M, Duh MS, Bailey RA, Piech CT, Lefebvre P, J Manag Care Pharm 2009 15 312 322
4. KDIGO 2012 clinical practice guidelines for the evaluation and management of chronic kidney disease. Kidney Disease: Improving Global Outcomes (KDIGO) CKD Working Group, Kidney Int Suppl 2013 3 1 1 150
5. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. National Kidney Foundation, Am J Kidney Dis 2002 5 Suppl 1 1 S266
6. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. Go AS, Chertow GM, Fan D, McColloch CE, Hsu CY, N Engl J Med 2004 351 1296 1305
7. Lower estimated GFR and higher albuminuria are associated with adverse kidney outcomes. A collaborative meta-analysis of general and high-risk population cohorts. Gansevoort RT, Matsushita K, van der Velde M, Astor BC, Woodward M, Levey AS, de Jong PE, Coresh J, Chronic Kidney Disease Prognosis Consortium, Kidney Int 2011 80 93 104
8. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Matsushita K, van der Velde M, Astor B, Woodward M, Levey A, Lancet 2010 375 2073 2081
9. Standards of medical care in diabetes-2014. American Diabetes Association, Diabetes Care 2014 37 suppl 1 5 S80
10. NHANES homepage. [ http://www.cdc.gov/nchs/nhanes.htm ]
11. Treatment approach and HbA1c control among US adults with type 2 diabetes: NHANES 1999-2004. Dodd AH, Colby MS, Boye KS, Fahlman C, Kim S, Briefel RR, Curr Med Res Opin 2009 25 1605 1613
12. 12 supplements: the National Health and Nutrition Examination Survey, 1999-2006. Reinstatler L, Qi YP, Williamson RS, Garn JV, Oakley GP, Diabetes Care 2012 35 327 333
13. Cardiovascular risk factors and complications associated with albuminuria and impaired renal function in insulin-treated diabetes. Doggen K, Nobels F, Scheen AJ, Van Crombrugge P, Van Casteren V, Mathieu C, J Diabetes Complications 2013 27 370 375
14. A new equation to estimate glomerular filtration rate. Levey AS, Stevens LA, Schmid CH, Zhang Y, Castro AF, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J, CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration), Ann Intern Med 2009 150 604 612
15. Using standardized serum creatinine values in the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate. Levey AS, Coresh J, Green T, Stevens LA, Zhang YL, Hendriksen S, Kusek JW, Van Lente F, Chronic Kidney Disease Epidemiology Collaboration, Ann Intern Med 2006 145 247 254 (Pubitemid 46768608)
16. Specifying weighting parameters. [ http://www.cdc.gov/nchs/tutorials/ nhanes/SurveyDesign/Weighting/intro.htm ]
17. Age standardization and population counts. [ http://www.cdc.gov/nchs/ tutorials/nhanes/NHANESAnalyses/AgeStandardization/age-standardization-intro. htm ]
18. National health interview survey. [ http://www.cdc.gov/nchs/nhis/nhis- 2010-data-release.htm ]
19. Prevalence of chronic kidney disease in US adults with undiagnosed diabetes or prediabetes. Plantinga LC, Crews DC, Coresh J, Miller ER, Saran R, Yee J, Hedgeman E, Pavkov M, Eberhardt MS, Williams DE, Powe NR, Clin J Am Soc Nephrol 2010 5 673 682
20. Prevalence of chronic kidney disease in the United States. Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, Eggers P, Van Lente F, Levey AS, JAMA 2007 298 2038 2047 (Pubitemid 350074801)
21. 2. Stevens LA, Schmid CH, Greene T, Zhang YL, Beck GJ, Froissart M, Hamm LL, Mauer M, Navis GH, Steffes MW, Eggers PW, Coresh J, Levey AS, Am J Kidney Dis 2010 56 486 495
22. Comparison of risk prediction using the CKD-EPI equation and the MDRD study equation for estimated glomerular filtration rate. Matsushita K, Mahmoodi BK, Woodward M, Embeson JR, Jafar TH, Jee SH, Polkinghorne KR, Shankar A, Smith DH, Tonelli M, Warnock DG, Wen CP, Gansevoort RT, Hemmelgarn BR, Levey AS, JAMA 2012 307 1941 1951
23. National Kidney Disease Education Program website. [ http://nkdep.nih. gov/lab-evaluation/gfr/estimating.shtml ]
24. Incidence of end-stage renal disease among persons with diabetes - - United States, 1990-2002. [ http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5443a2. htm ]
25. Effects of intensive blood pressure lowering on the progression of chronic kidney disease: a systematic review and meta-analysis. Lv J, Ehteshami P, Sarnak MJ, Tighiouart H, Jun M, Ninomiya T, Foote C, Rodgers A, Zhang H, Wang H, Strippoli GFM, Perkovic V, CMAJ 2013 185 949 957
26. Glucose-lowering drugs in patients with chronic kidney disease: a narrative review on pharmacokinetic properties. Anouts P, Bolignano D, Nistor I, Bilo H, Gnudi L, Heaf J, van Biesen W, [ http://ndt.oxfordjournals.org/content/ early/2013/12/08/ndt.gft462.long ]